SAM 2025

Back

27 - 29 March 2025 Bilbao, Spain

OAS2 - Oral Abstract Session 2 – Atopic Dermatitis

Friday 28 Mar, 08:15 AM - 09:45 AM Bilbao, Spain

Room 0C Oral Abstract Session

08:15 OA-08

BBT001: A Novel Tetravalent Bispecific Antibody Targeting IL4Ra and IL31 for Enhanced Atopic Dermatitis Therapy

08:27 OA-09

Burden of Atopic Dermatitis in Adults in Greece: Results from a Nationwide Survey

08:39 OA-10

Evolution of atopic keratoconjunctivitis in patients with severe to moderate atopic dermatitis treated with oral Janus kinase inhibitors

08:51 OA-11

Educational Needs of Parents of Children with Atopic Dermatitis

09:03 OA-12

Measurement of Transepidermal Water Loss in children with atopic dermatitis and healthy controls using a new technology

09:15 OA-13

Comparison of the proteomic profile in tears between patients with severe atopic dermatitis and severe asthma treated with Dupilumab

09:27 OA-14

Revealing Wheeze-like Bronchial Obstruction in Infants with Atopic Dermatitis Using Tidal Breathing Analysis